CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
CNBX Pharmaceuticals's gross profit for the twelve months ending Feb 28, 2018 was $8.13K, down 92.0% year over year. For fiscal 2017 it was $5.68K, down 94.9% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Aug 31, 2017 | $5.68K | -94.9% |
| FY2016 | Aug 31, 2016 | $112.50K | – |
| FY2015 | Aug 31, 2015 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | May 31, 2026 | $0 | -100.0% |
| Q2 FY2026CQ1 2026 | Feb 28, 2026 | $0 | – |
| Q3 FY2025CQ2 2025 | May 31, 2025 | $0 | -100.0% |
| Q2 FY2025CQ1 2025 | Feb 28, 2025 | $0 | -100.0% |
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | $34.42K | +1857.7% |
| Q2 FY2023CQ1 2023 | Feb 28, 2023 | $0 | -100.0% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | $3.31K | +110.4% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $1.93K | +55.3% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $1.76K | – |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $2.87K | -94.3% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $1.57K | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $1.24K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $0 | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $50.00K | – |
See a number that looks wrong?